Carboplatin dosing formulae - gender bias and the use of creatinine-based methodologies

By Calvert A.H.   Egorin M.J.  

European Journal of Cancer, Vol. 38, Iss. 1, 2002-01 ,pp. : 11-16

Elsevier

Access to resources Recommend Favorite

Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy

By Rubie H.   Doz F.   Vassal G.   Chastagner P.   Gentet J.-C.   Urien S.   Bastian G.   Drouard-Troalen L.   Barberi-Heyob M.   Catalin J.   Chatelut E.   on behalf of Pharmacology Group of the Societe Francaise de Pediatrie Oncologique  

European Journal of Cancer, Vol. 39, Iss. 10, 2003-07 ,pp. : 1433-1438

Elsevier

Access to resources Recommend Favorite

Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients - 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin

By Dittrich C.   Sevelda P.   Salzer H.   Obermair A.   Speiser P.   Breitenecker G.   Schemper M.   Kaider A.   on behalf of the Austrian Ovarian Cancer Study Group  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1129-1140

Elsevier

Access to resources Recommend Favorite

Serum biomarkers for detection of breast cancers: a prospective study

By Mathelin Carole   Cromer Anne   Wendling Corinne   Tomasetto Catherine   Rio Marie- Christine  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 83-90

Springer Publishing Company

Access to resources Recommend Favorite

Formula-based dosing for carboplatin - bedside estimate

By Jodrell D.I.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1299-1301

Elsevier

Access to resources Recommend Favorite